menu
    • menu

    Company profile for Ypsomed

    NEW Drugs in Dev: 3
    DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

    Virtual Booth

    Contact Supplier

    Biophore is a research-driven global pharmaceutical company focused on niche APIs for the generic industry.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-01-12

    Virtual Booth

    Contact Supplier

    LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.https://marketing.lgmpharma.com/LGM-CDMO

    Virtual Booth

    Contact Supplier

    Vamsi Labs is one of the major manufacturers of Anti-asthmatic, Anti-migraine & Anti-psychotic APIs.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-2026-02-09

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    The Ypsomed Group is a leading developer and manufacturer of injection and infusion systems for self-medication and a renowned diabetes specialist with over 35 years’ experience. As a leader in innovation and technology, Ypsomed is the preferred partner for pharmaceutical and biotech companies for the supply of pens, autoinjectors and infusion systems to administer liquid drugs. Ypsomed promotes and sells its product portfol...
    The Ypsomed Group is a leading developer and manufacturer of injection and infusion systems for self-medication and a renowned diabetes specialist with over 35 years’ experience. As a leader in innovation and technology, Ypsomed is the preferred partner for pharmaceutical and biotech companies for the supply of pens, autoinjectors and infusion systems to administer liquid drugs. Ypsomed promotes and sells its product portfolio under the umbrella brands mylife Diabetescare directly to patients or through pharmacies and clinics and under YDS Ypsomed Delivery Systems as business-to-business to pharmaceutical companies.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    YpsomedSwitzerland Flag
    Country
    Country
    Switzerland
    Address
    Address
    Brunnmattstrasse 6 3401 Burgdorf
    Telephone
    Telephone
    +41 (0)34 424 41 11
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.ypsomed.com/en/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/ypsomed-ag/
    youtube
    YouTube
    Twitter
    Twitter
    https://x.com/ypsomed

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    euroPLX 90 Lisbon

    Not Confirmed

    envelop Contact Supplier

    euroPLX 90 Lisbon

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    BD And Ypsomed Expand Biologics Partnership For Market Growth
    BD And Ypsomed Expand Biologics Partnership For Market Growth

    21 Jan 2026

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/bd-and-ypsomed-expand-partnership-to-address-rapidly-growing-biologics-market-302665913.html

    PR NEWSWIRE
    21 Jan 2026
    Share Share
    Ypsomed uBilds 1st Facility in US, Spending $248M for N.C. site
    Ypsomed uBilds 1st Facility in US, Spending $248M for N.C. site

    20 Oct 2025

    // FIERCE PHARMA

    https://www.fiercepharma.com/manufacturing/swiss-auto-injector-specialist-ypsomed-invests-248m-build-facility-nc

    FIERCE PHARMA
    20 Oct 2025
    Share Share
    Ypsomed sells diabetes business to focus on GLP-1 self-injectors
    Ypsomed sells diabetes business to focus on GLP-1 self-injectors

    23 Apr 2025

    // FIERCE BIOTECH

    https://www.fiercebiotech.com/medtech/ypsomed-carves-out-diabetes-business-512m-deal-focus-glp-1-self-injectors

    FIERCE BIOTECH
    23 Apr 2025
    Share Share
    Ypsomed and Sidekick Health launch digital obesity solution
    Ypsomed and Sidekick Health launch digital obesity solution

    07 Apr 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/ypsomed-and-sidekick-health-launch-a-collaborative-digital-health-solution-for-obesity-management-302420903.html

    PR NEWSWIRE
    07 Apr 2025
    Share Share
    Ypsomed will make injection pens for Novo Nordisk's CagriSema
    Ypsomed will make injection pens for Novo Nordisk's CagriSema

    22 Nov 2024

    // REUTERS

    https://www.reuters.com/business/healthcare-pharmaceuticals/ypsomed-will-make-injection-pens-novo-nordisks-cagrisema-says-source-2024-11-22/

    REUTERS
    22 Nov 2024
    Share Share
    Ypsomed hands off insulin pen needle business
    Ypsomed hands off insulin pen needle business

    28 Mar 2024

    // Conor Hale FIERCE BIOTECH

    https://www.fiercebiotech.com/medtech/ypsomed-hands-insulin-pen-needle-business-focus-smart-pump-autoinjector-development

    Conor Hale FIERCE BIOTECH
    28 Mar 2024
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search